The case for rejecting the amyloid cascade hypothesis
By Karl Herrup. Nature Neuroscience, 2015
734 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/1f8dc6d0b699a954b4c3f6002c0873e02260a451
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Claudio Franceschi
- M. Conte
- Daniela Monti
- Andrea Grignolio
- Bradley T. Hyman
- Paolo Garagnani
- A. Santoro
- M. Capri
In Physiology
- Claudio Franceschi
- V. Perry
- M. Conte
- Daniela Monti
- Andrea Grignolio
- Bradley T. Hyman
- Paolo Garagnani
- A. Santoro
Citations in the corpus
- The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates (2018, background): “The limits of the current conceptualization on AD pathogenesis and of the amyloid cascade hypothesis are well summarized by two Nature Neuroscience papers released in 2015 (131, 132).”
- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease (2017, background): “early 1990s [31–34] has become a dominant model for AD pathogenesis [35], although still controversial [36,37].”
- The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques (2019, background): “This has caused severe criticism on the amyloid cascade hypothesis for AD, raising questions about its validity in sporadic AD (Behl and Ziegler, 2017; Harrison and Owen, 2016; Herrup, 2015; Karran and Hardy, 2014; Makin, 2018; Selkoe and Hardy, 2016).”